PARTNERSHIP OPPORTUNITIES
Free Shipping in the U.S. for orders over $1000. Shop Now>>
10 December, 2023 by Anshul (neobio)
Ever wondered how exactly your muscles contract and relax so well? At the heart of this intricate process lies the α-smooth muscle actin (α-SMA), a unique protein responsible for this biological magic trick. However, the role of alpha smooth muscle actin goes beyond enabling just your muscles to move. This protein plays a crucial role in a vast array of physiological and pathological phenomena, making it a subject of great interest in biomedical research.
Alpha-smooth muscle actin, aka α-SMA or simply SMA, is a protein that belongs to the actin protein family. It is uniquely present in vascular smooth muscle cells and myofibroblasts. These cells form the concrete building blocks for smooth muscles found in various organs of our body, from the uterus to the intestines, and the blood vessels. Alpha smooth muscle actin not only provides these cells their structure but also their power to contract and relax, enabling our organs to perform their essential functions.
Finding reliable and specific antibodies for α-SMA often poses a challenge to many researchers. Frustrations can ignite from antibodies with poor specificity, leading to high background or nonspecific staining in the experiments. It is here that NeoBiotechnologies steps in, crafting highly validated, monospecific Rabbit Recombinant Monoclonal Antibodies ideal for various research applications.
In biomedical research, alpha smooth muscle actin is a beacon of cellular aggression. It serves as an essential marker to identify myofibroblasts, cells implicated in fibrotic diseases marked by an overproduction of extracellular matrix components. Investigations also relate this actin isoform to epithelial to mesenchymal transition, a process often observed in cancer metastasis.
In summary, research on alpha smooth muscle actin encompasses:
– Involvement in cell motility
– Identification of pericytes, myoepithelial cells, smooth muscle cells and myofibroblasts in normal, reactive, or neoplastic tissue
– Predictive potential in idiopathic pulmonary fibrosis and monitoring aggressive behavior in certain carcinomas.
Unveiling the deeper mechanisms of alpha smooth muscle actin paves the way for developing new therapeutic strategies towards various diseases. Companies like NeoBiotechnologies are contributing to this effort by providing reliable, highly validated antibodies, thereby empowering researchers in their quest to advance medical science.
Alpha Smooth Muscle Actin (α-SMA), a critical protein involved in smooth muscle contraction, is encoded by the ACTA2 gene. This gene, located on 10q22-q24 in humans, is responsible for producing an actin isoform that is primarily found in vascular smooth muscle cells. In other words, the ACTA2 gene provides the blueprint for creating α-SMA, which plays a pivotal role in muscle contraction and cell-generated mechanical tension.
In addition to its role in normal physiological processes, the ACTA2 gene is also implicated in various vascular diseases. Mutations in this gene have been associated with conditions such as thoracic aortic disease, coronary artery disease, stroke, and Moyamoya disease.
Alpha Smooth Muscle Actin is not only confined to cells of vascular smooth muscle but is also expressed in certain non-muscle cells, most notably myofibroblasts. Myofibroblasts, a type of cell involved in wound healing and fibrosis, are often identified by their expression of α-SMA. The presence of α-SMA gives these cells enhanced contractile properties, contributing to tissue remodeling and wound contraction.
In the context of cancer, α-SMA-positive myofibroblasts have been found in the stroma, the supportive tissue surrounding a tumor, and are associated with collagen synthesis around tumors.
One of the key roles of Alpha Smooth Muscle Actin is its involvement in tissue fibrosis, a process characterized by excess deposition of extracellular matrix components leading to tissue scarring and organ dysfunction. α-SMA acts as a marker for a subset of activated fibrogenic cells, known as myofibroblasts, which are considered crucial effector cells of tissue fibrogenesis.
The transformation of normal fibroblasts into myofibroblasts, and the subsequent development of fibrosis, is often mediated by the TGF-β pathway. Research cited on Wikipedia indicates that the TGF-β pathway enhances the contractile properties of hepatic stellate cells, leading to liver fibrosis and cirrhosis.
Understanding the precise role and function of alpha smooth muscle actin is vital in developing effective therapies for a host of diseases. This is where the contribution of NeoBiotechnologies, under the expertise of Dr. Atul K. Tandon, comes into play. Through their manufacture of highly validated, monospecific Rabbit Recombinant Monoclonal Antibodies, they provide valuable tools for researchers to investigate the function of α-SMA and its role in various diseases.
In the field of research and development, antibodies that can detect alpha smooth muscle actin (α-SMA) are indispensable. These antibodies are used in various research applications, including Enzyme-Linked Immunosorbent Assay (ELISA), Immunocytochemistry (ICC), Immunofluorescence, Immunohistochemistry (IHC), Immunoprecipitation (IP), Flow Cytometry, Simple Western, and Western Blot. These applications allow for the investigation of α-SMA’s presence and behavior in different types of cells and tissues, providing critical insights into physiological and pathological processes.
For instance, in the study of fibrosis – a condition characterized by excessive accumulation of extracellular matrix proteins leading to organ dysfunction – α-SMA is a marker for myofibroblasts, which are key effector cells in tissue fibrogenesis. Its detection helps researchers understand the progression of fibrosis and develop potential treatments.
Fibroblasts, the most common cells in connective tissue, play a significant role in tissue repair. They produce the extracellular matrix and collagen, contributing to the structural framework of tissues. Interestingly, various studies have shown that α-SMA is expressed in a subpopulation of fibroblasts and is instrumental in fibroblast contraction. This contraction is a crucial process in wound healing, tissue remodeling, and fibrosis development.
Understanding the role of α-SMA in fibroblast contraction is essential for biomedical research. It can provide insights into the mechanisms of wound healing and pathological conditions like fibrosis and cancer, thereby aiding in the development of therapeutic strategies.
NeoBiotechnologies, with over 1,000 highly validated, monospecific Rabbit Recombinant Monoclonal Antibodies in its catalog, is a key player in α-SMA research. The antibodies it manufactures are not only ideal for various research applications but also compatible with a diverse range of model species, including Human, Mouse, Rat, Primate, Bovine, Canine, Chicken, Feline, Rabbit, Monkey, Porcine, Sheep, and Zebrafish.
These antibodies offer researchers a reliable tool to investigate the function and role of α-SMA in different biological processes and pathological conditions. With NeoBiotechnologies’ commitment to providing high-quality antibodies, the company significantly contributes to advancing our understanding of α-SMA, paving the way for new discoveries and medical advancements in the biomedical field.
The study of alpha smooth muscle actin (α-SMA) is a rapidly evolving field, with researchers continually discovering new roles and functions for this important protein in various physiological processes and disease states. As our understanding of the α-SMA improves, so too does our ability to use this knowledge in the development of novel diagnostic and therapeutic approaches.
For instance, the identification of α-SMA as a key marker for myofibroblasts has led to breakthroughs in our understanding of fibrosis and wound healing. In the future, this could potentially pave the way for the design of targeted therapies to control myofibroblast activity and manage fibrotic diseases.
Another promising area of research is the role of α-SMA in cancer progression. As mentioned in the research, α-SMA-positive myofibroblasts have been linked to collagen synthesis around tumors, suggesting a potential role for α-SMA in tumor growth and metastasis.
The study of α-SMA has had a profound impact on biomedical science and medicine, shedding light on the fundamental mechanisms that drive cell differentiation, tissue repair, and disease progression. Its role in smooth muscle contraction is essential to a wide range of physiological functions, from blood vessel dilation to gastrointestinal movement, making it a critical player in human health and disease.
In addition, the ability of α-SMA to act as a reliable marker for myofibroblasts has proven invaluable in understanding tissue fibrogenesis, a key process in wound healing and fibrotic diseases. By enabling researchers to identify and study these cells, α-SMA has opened up new avenues for therapeutic intervention.
The antibodies developed by NeoBiotechnologies for α-SMA detection, such as their Rabbit Recombinant Monoclonal Antibodies, have been instrumental in these research advancements. As a provider of highly validated and specific antibodies, NeoBiotechnologies continues to support the scientific community’s quest for knowledge and the development of innovative solutions to pressing medical challenges.
For further reading, visit NeoBiotechnologies’ research area on muscle and explore their wide range of actin-related products.
